Activity not yet confirmed Verified 4 Nov 2026
Seneca Partners
North West England investment business, formed in 2010, that manages tax-advantaged products including a generalist VCT and provides equity and debt funding to UK SMEs, both private and AIM quoted.
- Type
- Fund manager
- Location
- Haydock, United Kingdom
- Stages
- Growth
- Backs
- Biotech and pharma, B2B software, Medtech and digital health
- Sectors
- Healthtech and life sciences, Biotech, Devtools, Generalist, Industrial, B2B
- SEIS / EIS
- EIS
- Fund size / AUM
- over £100m of tax-advantaged investments under management (About page)
- Portfolio mix
- Biotech and pharma 27%; B2B software 20%; Medtech and digital health 20%; Hardware 14%; Crypto and web3 3%; Fintech 3%; Climate and energy 3%; Consumer products 3%; Deep tech 3%; Tech-enabled services 2% (n=30)
- Website
- senecapartners.co.uk
Contacts on file
For Seneca Partners, the paid file holds: 8 named decision-makers with roles; firm contact email (domain checked).
Get UK Complete, $149 Free sample
One-time payment. No subscription. No account.
Notable investments
FreeAgentGear4musicEquals GroupScancell Holdings plcBright NetworkAptamer GroupStrip TinningArecor
Sources
- senecapartners.co.uk/
- senecapartners.co.uk/our-team/
- senecapartners.co.uk/portfolio/
- senecapartners.co.uk/about/
- senecapartners.co.uk/contact/
- senecapartners.co.uk/portfolio/strip-tinning-plc/
Last checked 4 Nov 2026. Is something wrong? Tell us.
Appears in 26 lists
Developer tools investors in the UK (30)Growth-stage developer tools investors (39)Industrial tech investors in the UK (56)Medtech investors in the UK (58)B2B investors in the UK (73)Growth-stage industrial tech investors (81)Biotech investors in the UK (92)EIS funds and investors in the UK (105)Growth-stage medtech investors (107)Growth-stage biotech investors (109)Growth-stage B2B investors (119)Growth-stage investors in the UK (137)Healthtech investors in the UK (194)Developer tools investors (216)SaaS investors in the UK (223)Growth-stage healthtech investors (316)Growth-stage SaaS investors (344)Industrial tech investors (387)Startup investors in the UK (416)B2B investors (438)Medtech investors (457)Biotech investors (484)Generalist investors (526)Growth-stage investors (705)Healthtech investors (1,207)SaaS investors (1,529)